Products - Rise In Oropouche Viral Activity

Rise In Oropouche Viral Activity

In the United States

For Research Use Only.

The Oropouche virus (similar signs as Zika Virus1) has caused multiple outbreaks across Central and South America. In 2024, cases have surged to 10,0002 in the Americas, with the United States reporting a 28% rise in travel-related infections within the past 10 days, mandating continuous monitoring of the infection by the CDC3

All Oropouche virus disease cases reported by location of residence, 2024

Oropouche Infections Cases
Source: https://www.cdc.gov/oropouche/data-maps/current-year-data.html

The content above is for scientific and information purposes only, not for clinical or medical application.

For Research Use Only. Not for use in diagnostic procedures.

EUROIMMUN is the only company to offer anti-Oropouche virus IgM and IgG ELISAs for research use only.

If you are interested in performing a research or scientific study, please contact our Scientific Affairs team at .

References

1. Oropouche Virus Disease Among U.S. Travelers — United States, 2024
2. Epidemiological Update Oropouche in the Americas Region – 6 September 2024
3. 2024 Oropouche Outbreak

Fill in the form below for more information from our Scientific Affairs team


    For product information, please contact the EUROIMMUN Sales Team

    2024 EUROIMMUN US

    Privacy Policy | Website Terms and Conditions | Cookie Notice and Settings | Sitemap